首页> 美国卫生研究院文献>Journal of Law and the Biosciences >Barred from better medicine? Reexamining regulatory barriers to the inclusion of prisoners in research
【2h】

Barred from better medicine? Reexamining regulatory barriers to the inclusion of prisoners in research

机译:禁止使用更好的药物?重新审查将囚犯纳入研究的监管障碍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In 2015, President Obama announced plans for the Precision Medicine Initiative® (PMI), an ambitious longitudinal project aimed at revolutionizing medicine. Integral to this Initiative is the recruitment of over one million Americans into a volunteer research cohort, the All of UsSM Research Program. The announcement has generated much excitement but absent is a discussion of how the All of Us Research Program—to be implemented within the context of social realities of mass incarcerations and racial disparities in criminal justice and healthcare—might excaberate health disparities. We examine how attainment of Initiative's stated goals of reflecting the diversity of the American population and including all who are interested in participating might be impeded by regulatory and administrative barriers to the involvement of participants who become incarcerated during longitudinal studies. Changes have been proposed to the federal policy for human subjects research protections, but current regulations and administrative policies—developed under a protectionist paradigm in response to scandalous research practices with confined populations—dramatically limit research involving prisoners. Our review provides rationale for the development of Initiative policies that anticipate recruitment and retention obstacles that might frustrate inclusivity and exacerbate health disparities. Furthermore, we question the effective ban on biomedical and behavioral research involving prisoners and advocate for regulatory reforms that restore participatory research rights of prisoners. Disparities in health and justice are intertwined, and without regulatory reforms to facilitate participatory research rights of prisoners and careful planning of viable and responsible recruitment, engagement, and retention strategies, Initiative could miss discovery opportunities, exacerbate health disparities, and increase levels of distrust in science.
机译:2015年,奥巴马总统宣布了精准医学计划(sup>®(PMI)的计划,这是一个雄心勃勃的纵向项目,旨在彻底改变医学。该计划不可或缺的一部分是招募超过一百万美国人加入自愿研究队列“我们所有人 SM 研究计划”。这项声明引起了极大的兴奋,但是却没有讨论如何在“大规模监禁”社会现实,刑事司法和医疗保健中的种族差距的背景下实施“我们所有人研究计划”可能会加剧健康差距。我们研究了倡议的既定目标如何实现,以反映美国人口的多样性,包括所有有兴趣参加的人,可能受到纵向研究期间被监禁的参与者参与的监管和行政障碍的阻碍。联邦已经提出了有关人类研究保护的联邦政策的更改,但是当前的法规和行政政策(在保护主义范式的基础上制定,以应对受限人群的丑闻研究实践)极大地限制了涉及囚犯的研究。我们的审查为制定倡议政策提供了理论依据,这些政策预期了可能招募包容性和加剧健康差异的招募和保留障碍。此外,我们质疑对囚犯进行生物医学和行为研究的有效禁令,并主张进行监管改革以恢复囚犯的参与性研究权利。卫生与司法方面的差距是交织在一起的,如果不进行监管改革以促进囚犯的参与性研究权利,并认真规划可行和负责任的招募,参与和保留策略,那么该倡议可能会错过发现机会,加剧健康差距,并增加人们的不信任感。科学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号